Agustin Latorre
Family Medicine · Miami, FLNPI 1477655462
Payments from drug & device makers
Across 265 payments — averaging $6872.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$471K
- Pfizer$372K
- Biohaven Pharmaceutical Holding Company Ltd.$372K
- Ironwood Pharmaceuticals, Inc$181K
- Takeda Pharmaceuticals U.S.A., Inc.$170K
- Acella Pharmaceuticals, LLC$111K
- plus $144K from 10 others
Across 38 payments — averaging $4338.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$128K
- Bausch Health US, LLC$33K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
What the payments were for
- Food & beverage$54100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 23 | $471,492 |
| Pfizer | 72 | $372,308 |
| Biohaven Pharmaceutical Holding Company Ltd. | 70 | $372,134 |
| Ironwood Pharmaceuticals, Inc | 14 | $180,816 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $169,892 |
| Acella Pharmaceuticals, LLC | 19 | $110,924 |
| AbbVie | 23 | $35,742 |
| Avion Pharmaceuticals | 3 | $23,638 |
| Dr.reddy's Laboratories,inc. | 4 | $17,400 |
| Bausch Health US, LLC | 3 | $15,432 |
| Paratek Pharmaceuticals, Inc. | 4 | $13,016 |
| Boehringer Ingelheim | 1 | $10,350 |
| Gilead | 2 | $10,100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $9,729 |
| Regeneron | 3 | $8,055 |
| Genentech USA, Inc. | 1 | $54 |
How this compares
$1,821,081 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Miami
- Keila HooverMiami$33.7M
- Jorge CasoMiami$22.6M
- David WyattMiami$13.7M
- Jose CardenasMiami$13.2M
- Lazaro GarciaMiami$10.3M
- Ibrahim Menendez PerezMiami$8.9M
- Aniel Navarro MarinMiami$7.3M
- Gilberto SecoMiami$6.8M
- Ramon LeonMiami$6.3M
- Eddy CapoteMiami$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.